Bharat Biotech is going to increase the production of Covaxin to 10-12 crore doses per month by July-end. Nearly 25 crore made-in-India vaccine doses are expected to be available by August. SII will also manufacture 10-12 crore doses by June-end. Bharat Biotech is a pioneering biotechnology company known for its world-class R&D and manufacturing capabilities.
10-12 cr Covaxin doses to be produced by July-end
